2026 NPPES data Dermatology Physician NPI 1417913245 MD
Verify on CMS →

REBECCA BAXT, MD

Dermatology Physician in PARAMUS, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
609
Medicare Part D claims · 231 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · [object Object]
Industry payments
$48.41
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: REBECCA BAXT, MD is a Dermatology Physician ([object Object]) practicing in PARAMUS, New Jersey with a Medicare Part D prescribing footprint of 609 claims across 231 beneficiaries — 10% brand-name prescribing . Their CMS MIPS Final Score of 0/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $48.41 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: REBECCA BAXT, MD reported a CMS MIPS final score of 0 out of 100, below the 83.1 national average, and filed 609 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

REBECCA BAXT, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

REBECCA BAXT, MD at a glance

Below national average

NPI registry status

Active

Issued 04/21/2006

NPI 1417913245

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

609 16% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

0/100 83.1% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in New Jersey

How Dermatology Physician compares to other specialties among New Jersey providers

New Jersey providers

Dermatology Physician share within New Jersey

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within New Jersey

Medicare quality performance — MIPS

REBECCA BAXT, MD's 2023 MIPS final score plotted against the Dermatology Physician national average

Below national average
MIPS Final Score
0/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 0/100 vs national avg 83.1

0%100%National avg83%0%
MIPS final score (Dermatology Physician) — 0/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

REBECCA BAXT, MD is a Dermatology Physician provider practicing in PARAMUS, New Jersey, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1417913245. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

REBECCA BAXT, MD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD credentials at 351 EVELYN ST, PARAMUS, NJ, 07652, with a listed phone of (201) 265-1300. NPI 1417913245 was issued on 04/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BAXT most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 609 prescription claims written by this provider, covering 231 Medicare beneficiaries and totaling roughly $42K in drug spend, split 10% brand-name and 90% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

351 EVELYN ST
PARAMUS, NJ 07652

Provider Details

NPI 1417913245
Specialty Dermatology Physician
Credentials MD
Gender Female
NPI Issued 04/21/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Avg: 83.1
0
Quality

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for REBECCA BAXT, MD. Source: openpaymentsdata.cms.gov.

Total received

$48

Largest payer

REVANCE THERAPEUTICS, INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

REBECCA BAXT, MD — brand share 10.0%
Specialty average (est.)

10% brand-name claims vs 90% generic, on 609 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

609
Total Claims
$42K
Total Drug Cost
231
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
769
Total Day Supply
20,521
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$21K
Generic Drug Cost
$21K
Antibiotic Claims
25

Patient Demographics

Average Patient Age
76.0 years
Avg HCC Risk Score
0.97
Gender Split
69% female / 31% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ketoconazole
77
Triamcinolone Acetonide
71
Hydrocortisone
66
Clobetasol Propionate
46
Mupirocin
42
Clindamycin Phosphate
33
Metronidazole
32
Fluocinonide
30
Doxycycline Hyclate
26
Tretinoin
24

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How REBECCA BAXT, MD fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

REBECCA BAXT, MD's 609 claims are below the specialty average of 729.

Nearby Dermatology Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as BAXT.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is REBECCA BAXT, MD's specialty?
REBECCA BAXT, MD specializes in Dermatology Physician and practices in PARAMUS, New Jersey. Credentials: MD.
How much does REBECCA BAXT, MD prescribe under Medicare Part D?
In 2023, REBECCA BAXT, MD wrote 609 Medicare Part D claims totaling $42K in drug costs for 231 beneficiaries.
What is REBECCA BAXT, MD's Medicare quality score?
REBECCA BAXT, MD has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is REBECCA BAXT, MD located?
REBECCA BAXT, MD is located at 351 EVELYN ST, PARAMUS, NJ, 07652. Phone: (201) 265-1300.
What is REBECCA BAXT, MD's NPI number?
REBECCA BAXT, MD's National Provider Identifier (NPI) is 1417913245, issued on 04/21/2006.
Does REBECCA BAXT, MD prescribe more brand-name or generic drugs?
REBECCA BAXT, MD's prescribing is 10% brand-name and 90% generic drugs by claim count, with $21K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does REBECCA BAXT, MD prescribe most often?
Based on 2023 Medicare Part D data, REBECCA BAXT, MD's most frequently prescribed drugs include Ketoconazole, Triamcinolone Acetonide, Hydrocortisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does REBECCA BAXT, MD accept Medicare?
REBECCA BAXT, MD appears in CMS Medicare data with 609 Part D claims and 231 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify REBECCA BAXT, MD's credentials?
REBECCA BAXT, MD's NPI is 1417913245 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology